MedPath
HSA Approval

FUCON INJECTION 20 mg/ml

SIN07796P

FUCON INJECTION 20 mg/ml

FUCON INJECTION 20 mg/ml

July 15, 1994

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

A03BB01

butylscopolamine

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL IND CO LTD

Active Ingredients

HYOSCINE N-BUTYLBROMIDE

20 mg/ml

Scopolamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FUCON INJECTION 20 mg/ml - HSA Approval | MedPath